Evidence map›Paper›PMID 36278650›Full record

ArticleJournal of functional biomaterials2022

Platelet Membrane-Encapsulated MSNs Loaded with SS31 Peptide Alleviate Myocardial Ischemia-Reperfusion Injury.

Zaiyuan Zhang, Zhong Chen, Ling Yang, Jian Zhang, Yubo Li, Chengming Li, Rui Wang, Xue Wang, Shuo Huang, Yonghe Hu and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of functional biomaterials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Mitochondria-targeted delivery strategies for age-related diseases.International journal of pharmaceutics: X · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zaiyuan ZhangCollege of Medicine, Southwest Jiaotong University, Chengdu 610031, China.
Zhong ChenDepartment of Ultrasound, The General Hospital of Western Theater Command of PLA, Chengdu 610083, China.
Ling YangSchool of Clinical Medicine, Chengdu University of TCM, Chengdu 610072, China.
Jian ZhangCollege of Medicine, Southwest Jiaotong University, Chengdu 610031, China.
Yubo LiCollege of Integrated Traditional Chinese and Western Medicine, Southwest Medical University, Luzhou 646000, China.
Chengming LiSchool of Clinical Medicine, Chengdu University of TCM, Chengdu 610072, China.
Rui WangDepartment of Ultrasound, The General Hospital of Western Theater Command of PLA, Chengdu 610083, China.
Xue WangSchool of Clinical Medicine, Chengdu University of TCM, Chengdu 610072, China.
Shuo HuangSchool of Clinical Medicine, Chengdu University of TCM, Chengdu 610072, China.
Yonghe HuCollege of Medicine, Southwest Jiaotong University, Chengdu 610031, China.
Jianyou ShiPersonalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.
Wenjing XiaoDepartment of Pharmacy, The General Hospital of Western Theater Command of PLA, Chengdu 610083, China.

Funding

Clini-cal Research and Transformation Fund of Sichuan Provincial People's Hospital 2021LZ03Indi-vidual drug therapy small molecule innovative medicine Sichuan Youth Science and Tech-nology Innovation Research team 2022JDTD0025Key project of Sichuan Provincial Health Commission 19ZD020Key Research and Develop-ment Program of Science and Technology Department of Sichuan Province 2019YFS0514National Natural Science Foundation of China 81402507National Natural Science Foundation of China 82073311Science & Technology Department of Sichuan Province 2020YFS0122Science & Technology Department of Sichuan Province No2018SZ0033Science & Technology Department of Sichuan Province No2019YFS0542
6 · The paper itself

Abstract

Clinically, antioxidant therapy is a potential strategy for myocardial ischemia-reperfusion injury (MI/RI), a common complication of acute myocardial ischemia. The H-D-Arg-Dmt-Ly-Phe-NH

Indexed as

drug deliveryischemia-reperfusionmitochondria-mediated apoptosisoxidative damageplatelet membrane

Identifiers

PMID36278650
PMCPMC9624354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.